While recent genome wide association studies have suggested novel low-grade glioma (LGG) stratification models based on a molecular classification, we explored the potential clinical utility of patient-derived cells. Specifically, we assayed glioma-associated stem cells (GASC) that are patient-derived stem cells representative of the glioma microenvironment.
A NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells
Ruaro, Maria Elisabetta;Isola, Miriam;Sorrentino, Marisa;Bourkoula, Evgenia;Manini, Ivana;Mangoni, Damiano;Toffoletto, Barbara;Caponnetto, Federica;Zanello, Andrea;Mariuzzi, Laura;Di Loreto, Carla;Beltrami, Antonio Paolo
;Cesselli, Daniela
2017-01-01
Abstract
While recent genome wide association studies have suggested novel low-grade glioma (LGG) stratification models based on a molecular classification, we explored the potential clinical utility of patient-derived cells. Specifically, we assayed glioma-associated stem cells (GASC) that are patient-derived stem cells representative of the glioma microenvironment.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
1099582D-13A2-4825-ACBF-4D19904E7424.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
6.23 MB
Formato
Adobe PDF
|
6.23 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.